Brendan Le Daré Selected Research

Voriconazole (Vfend)

1/2021

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan Le Daré Research Topics

Disease

5	Poisoning 11/2022 - 01/2019
2	Substance-Related Disorders (Drug Abuse) 10/2023 - 01/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2020
2	Wounds and Injuries (Trauma) 09/2021 - 07/2020
2	Gout 02/2019 - 04/2017
1	Sepsis (Septicemia) 01/2024
1	Flushing 01/2024
1	Unconsciousness (Loss of Consciousness) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 07/2023
1	Chronic Renal Insufficiency 01/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2023
1	Hypercalcemia (Milk Alkali Syndrome) 01/2023
1	Hyperparathyroidism 01/2023
1	Seizures (Absence Seizure) 03/2022
1	Drug-Related Side Effects and Adverse Reactions 12/2021
1	COVID-19 12/2021
1	Necrosis 11/2021
1	Mushroom Poisoning 08/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 02/2021
1	Pulmonary Aspergillosis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 08/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Angina Pectoris 01/2020
1	Inflammation (Inflammations) 02/2019
1	Neoplasms (Cancer) 02/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2019
1	Alcoholic Fatty Liver 02/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2019
1	Cysts 01/2019
1	Fibrosis (Cirrhosis) 04/2017
1	Hypoxia (Hypoxemia) 04/2016

Drug/Important Bio-Agent (IBA)

4	Ethanol (Ethyl Alcohol)IBA 02/2021 - 01/2019
3	PowdersIBA 12/2023 - 01/2022
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2024 - 01/2019
2	Heroin (Diamorphine)IBA 03/2022 - 09/2021
2	InflammasomesIBA 02/2021 - 02/2019
2	Acebutolol (Prent)FDA LinkGeneric 01/2020 - 01/2020
2	Purinergic Receptors (Receptors, Purine)IBA 02/2019 - 04/2017
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 01/2024
1	N- (2- hydroxybenzyl)- 2- (4- iodo- 2,5- dimethoxyphenyl)ethan- 1- aminiumIBA 12/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2023
1	cathinoneIBA 10/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2023
1	LithiumIBA 01/2023
1	CalciumIBA 01/2023
1	Carbofuran (Furadan)IBA 11/2022
1	Cocaine (Cocaine HCl)IBA 03/2022
1	Illicit Drugs (Recreational Drugs)IBA 03/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	RNA Polymerase II (RNA Polymerase B)IBA 11/2021
1	AmanitinsIBA 08/2021
1	Voriconazole (Vfend)FDA LinkGeneric 01/2021
1	Lysergic Acid Diethylamide (LSD)IBA 07/2020
1	Sympathomimetics (Sympathomimetic Amines)IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Purinergic P2X7 ReceptorsIBA 02/2019
1	Methanol (Carbinol)IBA 01/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019
1	AntidotesIBA 01/2019
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2019
1	XenonIBA 04/2016
1	Erythropoietin FDA Link 04/2016

Therapy/Procedure

1	Catheters 01/2024
1	Therapeutics 01/2023
1	Duration of Therapy 01/2023
1	Sclerotherapy 01/2019